← Compare landing
Merck KGaA vs Yongtai Technology
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Merck KGaA | Yongtai Technology |
|---|---|---|
| Summary | Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea. | Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing. |
| Services | Data not yet provided. |
|
| Modalities | Data not yet provided. | Data not yet provided. |
| Development capabilities | Data not yet provided. | Data not yet provided. |
| Manufacturing capabilities | Data not yet provided. | Data not yet provided. |
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/merck-kgaa/yongtaitech.md